Panelist Diaries: What makes a good endpoint in cancer management?
In Plato’s book, The Theaetetus, Socrates was at wrestling school, discussing what he believed ‘knowledge’ to be to his...
MDforLives
A checkpoint inhibitor gains FDA approval in endometrial cancer
On April 22, 2021, the US Food and Drug Administration (FDA) granted Accelerated Approval to dostarlimab (Jemperli, GlaxoSmithKline) as...
Recent developments in primary hyperoxaluria treatment
Primary hyperoxaluria (PH) is a rare genetic disease in which high levels of oxalate are produced and can deposit...
Cancer vaccines in the clinic and in trials
Most vaccines are given as prophylactics, agents that protect healthy individuals before exposure to a pathogen. By contrast, therapeutic...
New Findings Provide Hope for Neuroprotection in Glaucoma
Scientists at Karolinska Institutet and St. Erik Eye Hospital find new ways to treat glaucoma, a common neurodegenerative disease. A...
Lung Cancer – Navigating through the maze
When it comes to lung cancer, the patient and the physician often feel like Danny in The Shining, navigating...
FDA Approves Pembrolizumab, the First Anti-PD1 Therapy for HER2 Positive Gastric Cancer
The Food and Drug Administration grants accelerated approval to Merck’s Keytruda (pembrolizumab), the checkpoint inhibitor drug for HER2-positive gastric...
IpsiHand Stroke Rehab System Receives FDA Market Authorization
FDA has authorized marketing for the first-of-its-kind device to assist upper limb rehabilitation of stroke patients.1 In 2017, a...
FDA Approves First Trial of CRISPR for Sickle Cell Disease
The U.S Food and Drug Administration (FDA) has approved the first clinical trial of CRISPR to correct sickle cell...
First-in-class drug approved for bone marrow protection during chemotherapy
Chemotherapy can be lifesaving, but it can also damage bone marrow and cause blood cell counts to drop, sometimes...